Patents by Inventor David Sosnovik

David Sosnovik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Theranostic nucleic acid binding fluorescent nanoprobes and uses thereof
    Patent number: 11779661
    Abstract: The present disclosure provides nucleic acid binding nanoprobes having one or more fluorochromes and a polymer, where each of the fluorochromes is connected to the polymer, and methods of using the same.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: October 10, 2023
    Assignee: The General Hospital Corporation
    Inventors: David Sosnovik, Lee Josephson, Howard Chen
  • THERANOSTIC NUCLEIC ACID BINDING FLUORESCENT NANOPROBES AND USES THEREOF
    Publication number: 20190269802
    Abstract: The present disclosure provides nucleic acid binding nanoprobes having one or more fluorochromes and a polymer, where each of the fluorochromes is connected to the polymer, and methods of using the same.
    Type: Application
    Filed: November 8, 2017
    Publication date: September 5, 2019
    Inventors: David Sosnovik, Lee Josephson, Howard Chen
  • VITAL FLUOROCHROME CONJUGATES AND METHODS OF USE
    Publication number: 20120121509
    Abstract: The present invention provides compositions and methods based on vital fluorochrome conjugates that are useful for imaging dying and dead cells.
    Type: Application
    Filed: June 4, 2010
    Publication date: May 17, 2012
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Lee Josephson, Elisabeth Garanger, Scott Hilderbrand, David Sosnovik, Hushan Yuan